Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Netherton syndrome causes skin and hair issues, confirmed by "bamboo hair" under dermoscopy, with no cure but managed with topical treatments.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

ZPK helps skin cells mature and may affect skin health.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

MMP-19 may worsen skin diseases by affecting skin growth and inflammation.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.